Quick Takeaways
- Mark Corrigan has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $416,087.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Mark Corrigan
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Mark Corrigan is at least $416,087 dollars as of 10 Dec 2025. Mark Corrigan is the Director of Wave Life Sciences Ltd. and owns shares of Wave Life Sciences Ltd. (WVE) stock worth about $405.3K. Mark Corrigan is the Director of Nabriva Therapeutics plc and owns shares of Nabriva Therapeutics plc stock worth about $10.8K.
- Signature
- /s/ Mark Corrigan
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Mark Corrigan and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Wave Life Sciences Ltd. ($405,282).
- Past-year value change for that position: -$217,297.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Mark Corrigan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | Director | $405,282 | -$217,297 | -35% | 08 Dec 2025 |
| NBRV | Nabriva Therapeutics plc | Director | $10,805 | 02 Aug 2022 | ||
| TRVN | TREVENA INC | Director | 13 Jun 2024 |
Insider Transactions Reported by Mark Corrigan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.